0.76
5.56%
0.04
プレマーケット:
.76
前日終値:
$0.72
開ける:
$0.729
24時間の取引高:
437.49K
Relative Volume:
0.84
時価総額:
$16.35M
収益:
$49.59M
当期純損益:
$-15.61M
株価収益率:
-0.1327
EPS:
-5.7281
ネットキャッシュフロー:
$-32.55M
1週間 パフォーマンス:
+16.33%
1か月 パフォーマンス:
+2.43%
6か月 パフォーマンス:
+8.57%
1年 パフォーマンス:
-26.21%
Cosmos Health Inc Stock (COSM) Company Profile
名前
Cosmos Health Inc
セクター
電話
312-536-3102
住所
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
COSM を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
COSM | 0.76 | 16.35M | 49.59M | -15.61M | -32.55M | -5.7281 |
MCK | 628.27 | 81.25B | 330.19B | 2.54B | 4.31B | 25.31 |
COR | 245.69 | 47.76B | 293.96B | 1.51B | 3.00B | 8.53 |
CAH | 123.42 | 30.06B | 224.34B | 1.26B | 1.08B | 0.61 |
HSIC | 73.77 | 9.35B | 12.50B | 314.00M | 421.00M | 3.42 |
PDCO | 20.28 | 1.78B | 6.57B | 185.93M | -857.00M | 2.19 |
Cosmos Health Inc (COSM) 最新ニュース
Cosmos Health shareholders approve key proposals - Investing.com
Cosmos Health Picks Bitcoin for Its Treasury - Altcoin Buzz
Cosmos Health adds Bitcoin and Ethereum to treasury reserves - Cryptopolitan
Cosmos Health to accumulate BTC and Ethereum and accept crypto payments - TU News
Planning Ahead: Cosmos Health Looks to Add Bitcoin and Ethereum to Its Treasury - Bitcoin.com News
Another Publicly Traded Company Adds Bitcoin to Its Balance Sheet - Decrypt
Cosmos Health integrates bitcoin, ethereum as treasury reserve assets - TipRanks
Cosmos Health Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets - AccessWire
Cosmos Health reports steady Q3 financials, cuts costs - Investing.com India
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M - AccessWire
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gro - WICZ
ARMISTICE CAPITAL, LLC Acquires New Stake in Cosmos Health Inc - GuruFocus.com
Cosmos Health Inc. (COSM) Quarterly 10-Q Report - Quartzy
Cosmos Health Q3: Amazon UK Sales Surge 160% Despite Revenue Dip; Operating Costs Down 19% | COSM Stock News - StockTitan
Cosmos Health reports revenue growth and strategic expansions - Investing.com
Cosmos Health anticipates ‘substantial value creation’ by 2027 - TipRanks
Cosmos Health (COSM) Reports 18% Q1 Growth, Projects $155M Revenue by 2027 | COSM Stock News - StockTitan
Cosmos Health reports revenue growth and strategic expansions By Investing.com - Investing.com UK
Cosmos Health Issues Letter to Shareholders - AccessWire
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East - AOL
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% - Big News Network
CosmoFarm reports 8.62% revenue increase in 2024 By Investing.com - Investing.com Canada
CosmoFarm reports 8.62% revenue increase in 2024 - Investing.com India
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with - PharmiWeb.com
Cosmos Health’s Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% - StockTitan
Cointreau Is Shaking Up Holiday Entertaining with Limited-Edition Cointreau, Cosmos + Caviar Kit - Yahoo Finance
Cosmos Health (NASDAQ:COSM) versus Sinopharm Group (OTCMKTS:SHTDF) Financial Contrast - Defense World
Head to Head Survey: Cosmos Health (NASDAQ:COSM) and Sinopharm Group (OTCMKTS:SHTDY) - Defense World
Cosmos Healthcare Introduces Neuromap® and QPAN Model: AI-Driven Personalized Care for Autism & Neurological - EIN News
Virax Biolabs Group Limited Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland - Marketscreener.com
Contrasting Sinopharm Group (OTCMKTS:SHTDF) & Cosmos Health (NASDAQ:COSM) - Defense World
Analyzing McKesson Europe (OTCMKTS:CAKFY) and Cosmos Health (NASDAQ:COSM) - Defense World
Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews
An Epic Dystopia - The American Prospect
Cosmos Health (NASDAQ:COSM) vs. ScripsAmerica (OTCMKTS:SCRCQ) Critical Contrast - Defense World
Taking the lead: Cosmos Health Inc (COSM) - SETE News
Evaluating COSM’s financial ratios for a profitable investment - US Post News
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands - AccessWire
Company’s Banking Shares: Up -50.73% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
Investor’s Delight: Cosmos Health Inc (COSM) Closes Weak at 1.01, Down -8.18 - The Dwinnex
Cosmo First expects plastic business to turn profitable by the fourth quarter this year - CNBCTV18
Cosmos Health secures UK orders for antimicrobial wash By Investing.com - Investing.com Australia
Recovery room: Skye, Corbus mend post-Novo CB1 weight-loss data - BioWorld Online
Cosmos Health secures UK orders for antimicrobial wash - Investing.com
Cosmos Health signs deal for mpox detection kits in India - Investing.com India
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins - Lelezard
Financial Survey: ScripsAmerica (OTCMKTS:SCRCQ) versus Cosmos Health (NASDAQ:COSM) - Defense World
Cosmos Health Inc (COSM) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):